HIM
ABBV icon

HawsGoodwin Investment Management’s AbbVie ABBV Stock Holding History

HawsGoodwin Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$433K Hold
3,200
– – 0.13% 82
2021
Q3 		$345K Hold
3,200
– – 0.1% 81
2021
Q2 		$360K Hold
3,200
– – 0.11% 82
2021
Q1 		$346K Hold
3,200
– – 0.11% 79
2020
Q4 		$343K Buy
+3,200
New +$308K 0.11% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HawsGoodwin Investment Management's ABBV Position: Q4 2021 in Review

HawsGoodwin Investment Management held its AbbVie (ABBV) position steady in Q4 2021 at 3,200 shares worth $433K. The position accounts for 0.13% of the portfolio, ranked #82.

HawsGoodwin Investment Management first reported a position in ABBV in Q4 2020 and has held it in 5 quarters since. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • HawsGoodwin Investment Management held 3,200 shares of AbbVie worth $433K as of Q4 2021.
  • HawsGoodwin Investment Management left its AbbVie share count unchanged in Q4 2021.
  • AbbVie made up 0.13% of HawsGoodwin Investment Management's portfolio in Q4 2021, its #82 holding.
  • HawsGoodwin Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 5 quarters since.
  • 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on HawsGoodwin Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.